Biohaven Pharmaceutical Holding Co Ltd (BHVN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

215 CHURCH STREET NEW HAVEN, CT 06510

Biohaven Pharmaceutical Holding Company Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on the identification and development of clinical stage compounds targeting orphan neurologic indications and other neurological pathways.

Data based on most recent fiscal year report
Market Cap904.102 Million Shares Outstanding36.02 Million Avg Volume455.694 Thousand
1-Yr BETA vs S&P TR1.722 Current Ratio14.49 Quick Ratio14.49
View SEC Filings from BHVN instead.
Q2 2019 All Institutions Hedge Funds 1
To trade BHVN now:
Filers who had this stock in their top 10: 11 6 (0.62%)
13F Filers holding this stock: 195 59 (6.1%)
Aggregate 13F shares on 06/30/2019: 46.359 Million 15.083 Million
Aggregate 13F shares on 03/31/2019: 39.259 Million 10.503 Million
Percent change: 18.08% 43.60%
Funds creating new positions: 64 26
Funds Adding to an existing position: 81 25
Funds closing out their position: 35 10
Funds reducing their position: 39 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BHVN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

5 Thousand total shares from 1 transactions

Open Market Sells (S)

10 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

10 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

AGUIAR ERIC

  • Director
0 2019-09-11 4

BAILEY GREGORY

  • Director
2,587,601 2019-08-20 3

STOCK ELYSE CHIEF MEDICAL OFFICER

  • Officer
0 2019-08-08 1

CHA ALBERT

  • Director
1,266,488 2019-07-26 0

BERMAN ROBERT CHIEF MEDICAL OFFICER

  • Officer
790,550 2019-06-27 2

CONWAY CHARLES CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-06-27 2

GENTILE KIMBERLY SVP, CLINICAL OPERATIONS

  • Officer
0 2019-06-27 2

ENGELHART JAMES CHIEF FINANCIAL OFFICER

  • Officer
2,500 2019-06-27 2

CORIC VLAD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
934,130 2019-06-26 3

CHILDS JOHN W

  • Director
2,836,938 2019-06-26 3

DOOGAN DECLAN

  • Director
0 2019-05-21 8

GREGORY JULIA P

  • Director
0 2019-05-21 2

REPELLA ROBERT

  • Director
0 2019-05-21 1

JONES WILLIAM A JR CCO-MIGRAINE & COMMON DISEASE

  • Officer
0 2019-04-01 2

TILTON JOHN CHIEF COMMERCIAL OFFICER

  • Officer
1,614 2019-03-12 3

PORTAGE BIOTECH INC.

  • FORMER 10% OWNER
No longer subject to file 2018-01-19 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

AGUIAR ERIC - Director by spouse

2019-09-11 S 10,000 $45.00 d 0 0.00 indirect yes

AGUIAR ERIC - Director by spouse

2019-09-11 M 10,000 $25.51 a 10,000 0.00 indirect yes

AGUIAR ERIC - Director by spouse

2019-09-11 M 10,000 d 20,000 0.00 indirect yes

BAILEY GREGORY - Director

2019-08-20 P 5,000 $37.65 a 2,587,601 2,587,601.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments